Amenorrhoea
80 results
1 - 80
Amenorrhoea 
Lactational amenorrhoea method for family planning- Clomiphene citrate for ovulation induction in women with oligo‐amenorrhoea
- Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
- Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation
- Altering the time of menstruation
- Lactational amenorrhea for family planning
- Polycystic ovary syndrome (PCOS)
- Menopausal symptoms and hormone therapy
- Lower abdominal pain of gynaecological origin
- Hypothyroidism
- Excessive hair growth (hirsutism)
- Metformin for polycystic ovary syndrome
- Pituitary tumours
- Nipple discharge and mastitis in a non-lactating woman
- Abnormal menstrual bleeding
- Autoimmune hepatitis
- Mitoxantrone for multiple sclerosis: Cochrane systematic review
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding: Cochrane systematic review
- Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
- Progesterone receptor modulators for endometriosis
- Hormone therapy for sexual function in perimenopausal and postmenopausal women
- Adenomyosis
- Long-term adverse effects of antineoplastic agents
- Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
- Surgical methods for first trimester termination of pregnancy
- Hormonal contraception
- Aromatase inhibitors (letrozole) for infertile women with polycystic ovary syndrome
- Steroid doping
- Mitoxantrone for multiple sclerosis
- Selective progesterone receptor modulators (SPRMs) for uterine fibroids
- Hormonal contraception for women at risk of HIV infection
- Dysmenorrhoea
- Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia
- Interventions for emergency contraception
- Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis
- Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy
- Haemochromatosis
- Progestins for symptomatic treatment of endometriosis
- A patient with intellectual disability (ID) in a medical consultation
- Endometrial resection and ablation techniques for heavy menstrual bleeding
- Progestagens and anti‐progestagens for pain associated with endometriosis
- Levonorgestrel-releasing intrauterine system vs hysterectomy for treatment of menorrhagia
- Levonorgestrel intrauterine system vs. other forms of reversible contraceptives
- Pre‐operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
- Progestogen‐releasing intrauterine systems for heavy menstrual bleeding
- Danazol for heavy menstrual bleeding
- Progestogen-releasing intrauterine systems for heavy menstrual bleeding
- Optimal duration of exclusive breastfeeding
- Infertility
- Subdermal implants for contraception
- Hormone therapy for sexual function in perimenopausal and postmenopausal women
- Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome
- Acupuncture for polycystic ovarian syndrome
- Rehabilitation of patients with spinal cord injury, and problems associated with such injury